Tag:
Stemline Therapeutics
Latest Headlines
Latest Headlines
Stemline bets $50M IPO on a pair of cancer stem cell treatments
New York-based Stemline Therapeutics is making a bid to go public and raise $50 million to help fund its mid-stage work on a pair of cancer stem cell treatments.
Tiny Stemline's brain cancer vax grabs a little of ASCO's limelight
With headlines at ASCO zeroing in on star cancer drugs like vemurafenib , crizotinib and cabozantinib , it was difficult for some of the smaller biotechs on the scene to share in the limelight. But
